Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoping Yang

Showing results (221-230 of 229) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 229 results.
Blood Science (Baltimore, Md.)|June 4, 2024
Subcutaneous daratumumab in Chinese patients with relapsed or refractory multiple myeloma: an open-label, multicenter, phase 1 study (MMY1010)Gang An, Zheng Ge, Hongmei Jing, et al.
JMIR Public Health and Surveillance|April 29, 2022
Changes in Parental Attitudes Toward COVID-19 Vaccination and Routine Childhood Vaccination During the COVID-19 Pandemic: Repeated Cross-sectional Survey StudyQiang Wang, Shixin Xiu, Liuqing Yang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 24, 2024
Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male SubjectsWei Wang, Shengnan Zhang, Changlin Dou, et al.
Clinical Pharmacokinetics|February 3, 2023
Integrated Pharmacokinetics/Pharmacodynamics Model and Simulation of the Ticagrelor Effect on Patients with Acute Coronary SyndromeZhiyan Liu, Yaou Liu, Guangyan Mu, et al.
Clinical and Translational Science|March 2, 2022
Evaluation of the relationship between polymorphisms in CYP2C19 and the single-dose pharmacokinetics of omeprazole in healthy Chinese volunteers: A multicenter studyShuang Zhou, Ran Xie, Xiaodan Zhang, et al.
BMC Medicine|January 29, 2025
Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): a randomized, blinded, crossover trialXiexiong Zhao, Tao Liu, Qiong Yang, et al.
Frontiers in Endocrinology|April 24, 2023
Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trialZhijie Dai, Ronghua Zhu, Zhifeng Sheng, et al.
Nature Communications|September 29, 2025
An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: the DUBHE randomized clinical trialMu Xian, Feng Lan, Bing Yan, et al.
Circulation. Genomic and Precision Medicine|June 9, 2020
Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical TrialChengxian Guo, Yun Kuang, Honghao Zhou, et al.
Pageof 23

Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Blood Science (Baltimore, Md.)|June 4, 2024
Subcutaneous daratumumab in Chinese patients with relapsed or refractory multiple myeloma: an open-label, multicenter, phase 1 study (MMY1010)Gang An, Zheng Ge, Hongmei Jing, et al.
JMIR Public Health and Surveillance|April 29, 2022
Changes in Parental Attitudes Toward COVID-19 Vaccination and Routine Childhood Vaccination During the COVID-19 Pandemic: Repeated Cross-sectional Survey StudyQiang Wang, Shixin Xiu, Liuqing Yang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 24, 2024
Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male SubjectsWei Wang, Shengnan Zhang, Changlin Dou, et al.
Clinical Pharmacokinetics|February 3, 2023
Integrated Pharmacokinetics/Pharmacodynamics Model and Simulation of the Ticagrelor Effect on Patients with Acute Coronary SyndromeZhiyan Liu, Yaou Liu, Guangyan Mu, et al.
Clinical and Translational Science|March 2, 2022
Evaluation of the relationship between polymorphisms in CYP2C19 and the single-dose pharmacokinetics of omeprazole in healthy Chinese volunteers: A multicenter studyShuang Zhou, Ran Xie, Xiaodan Zhang, et al.
BMC Medicine|January 29, 2025
Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): a randomized, blinded, crossover trialXiexiong Zhao, Tao Liu, Qiong Yang, et al.
Frontiers in Endocrinology|April 24, 2023
Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trialZhijie Dai, Ronghua Zhu, Zhifeng Sheng, et al.
Nature Communications|September 29, 2025
An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: the DUBHE randomized clinical trialMu Xian, Feng Lan, Bing Yan, et al.
Circulation. Genomic and Precision Medicine|June 9, 2020
Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical TrialChengxian Guo, Yun Kuang, Honghao Zhou, et al.
Pageof 23